An accurate method for comparing transcript levels of two alleles or highly homologous genes: Application to fibrillin transcripts in Marfan patients' fibroblasts

Genome Research

Volumn 6, Issue 5, 1996, Pages 392-403

  Karttunen, Leena ^a   Lönnqvist, Lasse ^a   Godfrey, Maurice ^b   Peltonen, Leena ^a   Syvänen, Ann Christine ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRILLIN; GLYCOPROTEIN; MESSENGER RNA;

ALLELE; ARTICLE; BONE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DNA TRANSCRIPTION; EXTRACELLULAR MATRIX; EYE DISEASE; FIBROBLAST; FIBROBLAST CULTURE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MARFAN SYNDROME; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STOP CODON; SYMPTOM;

EID: 0029973249     PISSN: 10549803     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.6.5.392     Document Type: Article

References (17)

1. Becker-Andre, M. and K. Hahlbrock. 1989. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res. 17: 9437-9446.
2. Cheng, J., M. Fogel-Petrovic, and L.E. Maquat. 1990. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol. Cell. Biol. 10: 5215-5225.
3. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
4. Corson, G.M., S.C. Chalberg, H.C. Dietz, N.L. Charbonneau, and L.Y. Sakai. 1993. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics 17: 476-484.
5. Dietz, H.C., and R. Pyeritz. 1995. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum. Mol. Genet. 4: 1799-1809.
6. Dietz, H.C., I. McIntosh, L.Y. Sakai, G.M. Corson, S.C. Chalberg, R.E. Pyeritz, and C.A. Francomano. 1993a. Four novel FBN1 mutations: Significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 17: 468-475.
7. Dietz, H.C., D. Valle, C.A. Francomano, R.J. Kendzior Jr., R.E. Pyeritz, and G.R. Cutting. 1993b. The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259: 680-683.
8. Dietz, H.C., G.R. Cutting, R.E. Pyetitz, C.L. Maslan, L.Y. Sakai, G.M. Corson, E.G. Puffenberger, A. Hamosh, E.J. Nanthakumar, S.M. Curristin, G. Stetten, G.A. Meyers, and C.A. Francomano. 1991. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352: 337-339.
9. Gilliland, G., S. Perrin, K. Blanchard, and F. Bunn. 1990. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. 87: 2725-2729.
10. Ikonen, E., T. Manninen, L. Peltonen, and A.C. Syvänen. 1992. Quantitative determination of rare mRNA species by PCR and solid-phase minisequencing. PCR Methods Applic. 1: 234-240.
11. Kainulainen, K., L.Y. Sakai, A. Child, F.M. Pope, L. Puhakka, L. Ryhänen, A. Palotie, I. Kaitila, and L. Peltonen. 1992. Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. Proc. Natl. Acad. Sci. 89: 5917-5921.
12. Kainulainen, K., L. Karttunen, L. Puhakka, L. Sakai, and L. Peltonen. 1994. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nature Genet. 6: 64-69.
13. Karttunen, L., M. Raghunath, L. Lönnqvist, and L. Peltonen. 1994. A compound- heterozygous Marfan patient: Two defective fibrillin alleles result in lethal phenotype. Am. J. Hum. Genet. 55: 1083-1091.
14. Vandenplas, S., I. Wild, A. Grobler-Rabie, K. Brebner, M. Ricketts, G. Wallis, A. Bester, C. Boyd, and C. Mathew. 1984. Blot hybridization analysis of genomic DNA. J. Med. Genet. 21: 164-172.
15. Wang, M., J.-Y. Wang, J. Cisler, K. Imaizumi, B.K. Burton, M.C. Jones, J.J. Lamberti, and M. Godfrey. 1996. Three novel fibrillin mutations in exons 25 and 27: Classical versus neonatal Marfan syndrome. Hum. Mutat. (in press).
16. Zhang, H., S.D. Apfelroth, W. Hu, E.G. Davis, C. Sanguineti, J. Bonadio, R.P. Mecham, and F. Ramirez. 1994. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J. Cell. Biol. 124: 855-863.
17. Zhang, H., W. Hu, and F. Ramirez. 1995. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J. Cell. Biol. 129: 1165-1176.